Three years in the past, the DNA-testing agency 23andMe was a large success, with a share value greater than Apple’s.
However, from these heady days of tens of millions of individuals speeding to ship it saliva samples in return for detailed reviews about their ancestry, household connections and genetic make-up, it now finds itself preventing for its survival.
Its share value has plummeted and this week it narrowly avoided being delisted from the inventory market.
And naturally this can be a firm that holds probably the most delicate knowledge conceivable about its prospects, elevating troubling questions on what would possibly occur to its large – and intensely helpful – database of particular person human DNA.
When contacted by the BBC, 23andMe was bullish about its prospects – and insistent it remained “dedicated to defending buyer knowledge and constantly centered on sustaining the privateness of our prospects.”
However how did what was as soon as probably the most talked-about tech companies get to the place the place it has to reply questions on its very survival?
DNA gold rush
Not so way back, 23andMe was within the public eye for all the appropriate causes.
Its well-known prospects included Snoop Dogg, Oprah Winfrey, Eva Longoria and Warren Buffet – and tens of millions of customers had been getting sudden and life-changing outcomes.
Some individuals found that their mother and father weren’t who they thought they had been, or that that they had a genetic pre-disposition to severe well being situations. Its share value rocketed to $321.
Quick ahead three years and that value has slumped to only beneath $5 – and the corporate is value 2% of what it as soon as was.
What went improper?
In accordance with Professor Dimitris Andriosopoulos, founding father of the Accountable Enterprise Unit at Strathclyde College, the issue for 23andMe was twofold.
Firstly, it didn’t actually have a seamless enterprise mannequin – when you’d paid in your DNA report, there was little or no so that you can return for.
Secondly, plans to make use of an anonymised model of the gathered DNA database for drug analysis took too lengthy to change into worthwhile, as a result of the drug improvement course of takes so a few years.
That leads him to a blunt conclusion: “If I had a crystal ball, I’d say they’ll perhaps final for a bit longer,” he advised the BBC.
“However because it at the moment is, for my part, 23andMe is very unlikely to outlive.”
The issues at 23andMe are mirrored within the turmoil in its management.
The board resigned in the summer and solely the CEO and co-founder Anne Wojcicki – sister of the late YouTube boss Susan Wojcicki and ex-wife of Google co-founder Sergei Brin – stays from the unique line-up.
Rumours have swirled that the agency will shortly both fold or be bought – claims that it rejects.
“23andMe’s co-founder and CEO Anne Wojcicki has publicly shared she intends to take the corporate non-public, and isn’t open to contemplating third occasion takeover proposals,” the corporate mentioned in a press release.
However that hasn’t stopped the hypothesis, with rival agency Ancestry calling for US competitors regulators to get entangled if 23andMe does find yourself on the market.
What occurs to the DNA?
Firms rising and falling is nothing new – particularly in tech. However 23andMe is totally different.
“It is worrying due to the sensitivity of the info,” says Carissa Veliz, creator of Privateness is Energy.
And that’s not only for the people who’ve used the agency.
“When you gave your knowledge to 23andMe, you additionally gave the genetic knowledge of your mother and father, your siblings, your kids, and even distant kin who didn’t consent to that,” she advised the BBC.
David Stillwell, professor of computational social science at Cambridge Decide Enterprise College, agrees the stakes are excessive.
“DNA knowledge is totally different. In case your checking account particulars are hacked, it is going to be disruptive however you will get a brand new checking account,” he defined.
“In case your (non-identical) sibling has used it, they share 50% of your DNA, so their knowledge can nonetheless be used to make well being predictions about you.”
The corporate is adamant these sorts of issues are with out basis.
“Any firm that handles client data, together with the kind of knowledge we accumulate, there are relevant knowledge protections set out in regulation required to be adopted as a part of any future possession change,” it mentioned in its assertion.
“The 23andMe phrases of service and privateness assertion would stay in place except and till prospects are introduced with, and conform to, new phrases and statements.”
There are additionally authorized protections which apply within the UK beneath its model of the info safety regulation, GDPR, whether or not the agency goes bust or adjustments palms.
Even so, all firms could be hacked – as 23andMe was 12 months ago.
And Carissa Veliz stays uneasy – and says finally a a lot sturdy strategy is required if we need to preserve our most private data secure.
“The phrases and situations of those firms are usually extremely inclusive; whenever you give out your private knowledge to them, you permit them to do just about something they need with it,” she mentioned.
“Till we ban the commerce in private knowledge, we’re not properly protected sufficient.”
Extra reporting by Tom Gerken